Table 2.
Minors Scoring For The Original Articles Included
| No | Author | Q1 | Q2 | Q3 | Q4 | Q5 | Q6 | 7 | Q8 | Q9 | Q10 | Q11 | Q12 | Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | DIXON | 2 | 2 | 2 | 2 | 0 | 2 | 0 | 2 | 2 | 2 | 2 | 2 | 20 |
| 2 | BAE | 2 | 0 | 0 | 2 | 0 | 2 | 2 | 0 | 2 | 2 | 0 | 0 | 14 |
| 3 | GHADEROSHI | 2 | 2 | 0 | 2 | 0 | 2 | 2 | 0 | 2 | 2 | 0 | 0 | 14 |
| 4 | GLIKSON | 2 | 2 | 0 | 2 | 0 | 2 | 0 | 0 | 2 | 2 | 2 | 0 | 14 |
| 5 | HUNTER | 2 | 2 | 0 | 2 | 0 | 2 | 2 | 0 | 2 | 2 | 1 | 0 | 15 |
| 6 | KAHEKATA | 2 | 2 | 2 | 2 | 0 | 1 | 0 | 0 | 1 | 2 | 1 | 1 | 14 |
| 7 | KILEEN | 2 | 0 | 0 | 2 | 0 | 2 | 0 | 0 | 2 | 1 | 2 | 1 | 12 |
| 8 | MAGLIULO | 2 | 2 | 2 | 2 | 0 | 2 | 2 | 0 | 2 | 2 | 2 | 1 | 19 |
| 9 | MARCHIONI | 2 | 2 | 0 | 2 | 0 | 2 | 2 | 0 | 2 | 2 | 0 | 0 | 14 |
| 10 | PRESUTTI | 2 | 2 | 0 | 2 | 0 | 2 | 2 | 0 | 2 | 2 | 0 | 1 | 15 |
Q1- Clearly stated aim; Q2- Inclusion of consequetive patients; Q3- prospective data; Q4- End point data mentioned; Q5- Unbiased (blinding); Q6- Follow-up period adequate; Q7- Lost to follow-up < 5%; Q8- Prospective study size calculation; Q9- Control group appropriate; Q10- Same period of evaluation for both groups; Q11- Similar groups; Q12- Appropriate statistical analysis